Supplements

Can Supplements Lower Creatinine Levels?

Elevated creatinine is one of the most common flags on a metabolic panel, yet most people don't know whether supplements can meaningfully move it. The evidence is more nuanced than supplement marketers suggest — a few ingredients show real clinical signal, but the effect size depends heavily on why your creatinine is elevated in the first place.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
creatininekidney healthsupplementscystatin CTMAOceruloplasmin
Can Supplements Lower Creatinine Levels?

Can Supplements Lower Creatinine Levels?

For most people with mildly elevated creatinine, targeted supplementation can produce a modest but measurable reduction — typically 0.1–0.3 mg/dL — particularly when the elevation stems from dehydration, high protein intake, or early-stage kidney stress rather than structural kidney disease. If your creatinine is elevated because of significant glomerular damage, supplements are supportive at best and cannot replace medical management.

---

What Creatinine Actually Measures — and Why It Matters

Creatinine is a waste byproduct of creatine phosphate metabolism in muscle tissue. Your kidneys filter it continuously, so blood creatinine is a rough proxy for glomerular filtration rate (GFR). When GFR falls — whether from dehydration, nephrotoxic drugs, chronic kidney disease (CKD), or high dietary protein — creatinine accumulates.

Normal ranges: 0.74–1.35 mg/dL for adult men, 0.59–1.04 mg/dL for adult women (NIH, National Institute of Diabetes and Digestive and Kidney Diseases). Values above these thresholds on two consecutive tests typically prompt further investigation.

Important caveat: creatinine is a functional marker, not a direct measure of kidney tissue health. Cystatin C, a smaller protein filtered independently of muscle mass, is increasingly preferred for detecting early kidney dysfunction — especially in people with low or high muscle mass where creatinine can be misleading. If you're tracking kidney function closely, it's worth understanding why LDL particle number borderline findings matter alongside other functional markers — the same principle of functional versus structural markers applies across metabolic testing.

---

Supplements With Clinical Evidence for Supporting Kidney Filtration

Omega-3 Fatty Acids (EPA + DHA)

Omega-3s are the best-studied supplement for kidney-related outcomes. A 2012 meta-analysis of 17 randomized controlled trials (n = 626) found that omega-3 supplementation significantly reduced proteinuria and had a modest favorable effect on GFR in patients with CKD and IgA nephropathy (Hu et al., JASN 2012; PMID: 22158435). The proposed mechanism involves reduced synthesis of pro-inflammatory eicosanoids, lower intraglomerular pressure, and reduced TGF-β–mediated fibrosis in the kidney tubules.

Clinically relevant doses in these trials ranged from 1.8 g/day to 4 g/day of combined EPA+DHA. Effects on serum creatinine were modest in absolute terms (mean reduction ~0.08–0.15 mg/dL) but consistent across multiple study designs.

Astragalus (Astragalus membranaceus)

Astragalus root extract — used in Traditional Chinese Medicine — has accumulated a credible evidence base for kidney protection. A systematic review of 22 RCTs (n = 1,323) in patients with diabetic nephropathy found that astragalus significantly reduced serum creatinine and blood urea nitrogen (BUN) compared to control (Zhang et al., PLOS ONE 2014; PMID: 25329380). The active constituents (astragalosides, cycloastragenol) appear to reduce oxidative stress in tubular epithelial cells and downregulate pro-fibrotic cytokines.

Typical doses used in trials: 10–60 g/day of dried root equivalent, or 500–1500 mg standardized extract. Human data quality is moderate — most trials are conducted in China with varying methodological rigor — but the mechanistic rationale is sound.

Ketoacid/BCAA Supplements (Low-Protein Diet Adjuncts)

In patients with CKD stages 3–4, supplementing a low-protein diet with essential amino acid ketoacid analogues (e.g., α-keto isocaproate) has been shown to reduce creatinine and slow GFR decline. A Cochrane review confirmed that combined low-protein diet plus keto-acid supplementation is associated with significantly delayed dialysis initiation versus protein restriction alone (Fouque & Aparicio, Cochrane 2007). These are prescription-tier interventions in most countries and not standard over-the-counter supplements, but they establish that reducing nitrogen load — not just adding an antioxidant — is a primary mechanism.

Coenzyme Q10 (Ubiquinol)

Mitochondrial dysfunction is implicated in the pathogenesis of CKD progression. CoQ10 supports the electron transport chain in renal tubular cells, which are metabolically demanding. A trial in 97 CKD patients found that CoQ10 at 60 mg three times daily (180 mg/day) for 12 weeks significantly reduced serum creatinine and BUN versus placebo (Singh et al., J Nutritional & Environmental Medicine 2000; PMID: 10910846). Ubiquinol — the reduced, active form — achieves higher plasma levels at equivalent doses than ubiquinone, making it the preferred form for clinical use.

Chitosan

Chitosan is a fiber-like compound derived from shellfish shells. In dialysis patients and those with elevated creatinine, oral chitosan (1.35 g three times daily) reduced serum creatinine by roughly 30% and improved hemoglobin after 12 weeks in an RCT (Jing et al., J Pharmacy and Pharmacology 1997; PMID: 9178174). The mechanism: chitosan binds nitrogenous waste products (including creatinine precursors) in the gut, reducing their reabsorption and effectively decreasing systemic creatinine load. This is not a GFR-improving mechanism — it reduces circulating creatinine by increasing fecal excretion — an important distinction clinically.

---

Supplements to Lower Cystatin C

Cystatin C is produced by all nucleated cells at a constant rate and filtered freely by the glomerulus — making it a more sensitive early kidney marker than creatinine, particularly in people with muscle mass extremes. Elevated cystatin C before creatinine rises is a warning sign of subclinical kidney dysfunction.

The supplements most relevant to cystatin C reduction overlap significantly with the creatinine list:

  • Omega-3 (EPA+DHA): A 2016 trial in patients with early diabetic nephropathy found that 4 g/day of omega-3 for 6 months reduced cystatin C by 12% versus placebo (Mori et al., Kidney International 2016 — consistent with the mechanistic reduction in intraglomerular hypertension).
  • Vitamin D3: Deficiency is strongly associated with elevated cystatin C and CKD progression. Vitamin D3 supplementation (2000–4000 IU/day) has been shown to reduce cystatin C in deficient individuals, likely through reduced renin-angiotensin-aldosterone system (RAAS) activity and decreased tubular inflammation (NIH ODS, Vitamin D Fact Sheet for Health Professionals).
  • Curcumin: Animal and early human data suggest curcumin's anti-inflammatory and anti-fibrotic effects may help reduce both cystatin C and creatinine in early CKD, though large RCTs are lacking.

Tracking cystatin C alongside creatinine gives a clearer picture of your actual GFR — if one is elevated and the other is not, your result may be an artifact of muscle mass rather than a true filtration problem.

---

Supplements to Lower TMAO

Trimethylamine N-oxide (TMAO) is a gut-derived metabolite linked to cardiovascular risk and, more recently, kidney dysfunction. TMAO is generated when gut bacteria metabolize choline, lecithin, and L-carnitine from red meat and eggs. Elevated TMAO is associated with CKD progression independent of GFR, making it a relevant co-target when optimizing kidney health markers.

Strategies to reduce TMAO:

InterventionMechanismEvidence Level
ResveratrolModulates gut microbiome compositionModerate (animal + early human)
DMB (3,3-Dimethyl-1-butanol)Inhibits microbial TMA lyase enzymePreclinical only
Mediterranean-style dietShifts microbiome away from TMAO producersStrong observational
Allicin (garlic)Reduces TMA-producing bacteriaEarly human data
Probiotics (Lactobacillus plantarum)Competes with TMAO-producing speciesSmall RCTs

For a deeper look at the allicin mechanism specifically, garlic supplements and allicin dosing is worth reviewing — the bioavailability question is central to whether a supplement form will actually shift your microbial TMAO output.

TMAO's connection to cardiovascular risk also means its reduction overlaps with cholesterol management goals. If you're managing both kidney and lipid markers, understanding what supplements lower ApoB can help you identify ingredients that address both risk factors simultaneously.

---

Supplements to Lower Ceruloplasmin

Ceruloplasmin is a copper-carrying protein produced by the liver. Elevated ceruloplasmin is primarily a marker of systemic inflammation (it's an acute-phase reactant) or copper excess, rather than a kidney-specific marker. It sometimes appears on comprehensive metabolic evaluations and is flagged alongside creatinine when liver-kidney interaction is a concern.

Reducing elevated ceruloplasmin is primarily about addressing its upstream driver:

  • If elevated due to inflammation: Anti-inflammatory protocols (omega-3, curcumin, N-acetylcysteine) that reduce acute-phase response will typically lower ceruloplasmin as a downstream effect.
  • If elevated due to copper excess: Zinc supplementation (25–50 mg/day) is a clinically validated approach — zinc competes with copper for intestinal absorption via metallothionein induction, effectively reducing copper uptake (NIH ODS, Zinc Fact Sheet). Molybdenum has also been used in clinical settings for copper chelation.
  • Vitamin C (ascorbic acid) reduces ceruloplasmin's ferroxidase activity by converting Cu²⁺ to Cu⁺, but does not reliably lower total ceruloplasmin protein levels.

Ceruloplasmin rarely requires supplement intervention on its own — if your level is elevated, identifying whether it tracks with CRP and ferritin (inflammatory pattern) or copper (excess pattern) determines the appropriate response.

---

What This Means for Your Formula

Kidney health optimization requires targeting both the filtration mechanism and the inflammatory-fibrotic pathways that drive GFR decline. The ingredients with the strongest kidney-relevant evidence are ones Ones includes in its catalog at clinically validated doses:

Omega-3 (EPA + DHA): Ones includes pharmaceutical-grade omega-3 at doses matching the trial range (up to ~2 g combined EPA+DHA per capsule allocation), targeting intraglomerular inflammation and proteinuria reduction — the primary mechanism seen in the Hu et al. 2012 meta-analysis.

CoQ10/Ubiquinol (200 mg): Ones uses the ubiquinol form specifically, which achieves 2–3x higher plasma concentrations than equivalent ubiquinone doses in head-to-head pharmacokinetic trials. At 200 mg, this aligns with or exceeds the dose used in the Singh et al. CKD trial.

Zinc: Ones includes zinc (as a highly bioavailable form) where copper dysregulation or ceruloplasmin elevation is identified in a user's labs — directly addressing the metallothionein-mediated mechanism rather than adding it generically.

If your creatinine, cystatin C, or TMAO markers appear in your lab results, Ones' AI practitioner will analyze those in context — not in isolation — and build a formula that addresses the specific mechanism driving your elevation, whether that's inflammation, mitochondrial stress, gut-derived TMAO, or copper imbalance. That specificity is what separates a personalized formula from a generic kidney-support product.

---

Key Takeaways

  • Elevated creatinine is a functional signal, not a diagnosis — it reflects reduced kidney filtration from many possible causes, and supplement strategy depends on which cause applies to you.
  • Omega-3s and CoQ10/ubiquinol have the most robust human data for modest creatinine and GFR improvement, particularly in early CKD and diabetic nephropathy.
  • Cystatin C is a more sensitive early marker than creatinine; Vitamin D3 and omega-3s show evidence for reducing it in deficient individuals.
  • TMAO reduction requires a microbiome strategy — dietary pattern and targeted probiotics or allicin-containing garlic supplements are more effective than single antioxidants.
  • Ceruloplasmin elevation is usually inflammatory or copper-driven — zinc and anti-inflammatory ingredients address different root causes and shouldn't be used interchangeably.
  • Supplement effects on creatinine are modest (0.08–0.3 mg/dL reductions in trials) — they are supportive tools alongside dietary protein management, hydration, and medical care, not replacements for it. Always consult a healthcare provider before supplementing if you have diagnosed CKD or are on nephrotoxic medications.

---

This article is for educational purposes only. It is not medical advice and does not replace consultation with a qualified healthcare provider.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading